Success Stories

Data Science: Improving care for patients with cancer

Life sciences is an ever-evolving industry that continues to push the landscape in how we treat diseases, develop new modalities, and redefine the careers created within this ecosystem. One such...

In Fuller Detail: Bits to Bytes awardee aims to break through imaging limitations in hemorrhagic stroke treatment

According to the Brain Aneurism Foundation, it is estimated that approximately 6 million people in the United States (1 in 50) have a brain aneurysm and that approximately 30,000 people...

Boston Public Schools: Biotechnology an Opportunity for All Students

In 2019, the MLSC awarded nearly $1.14 million in STEM equipment and professional development funding to 36 public middle schools and high schools in the five school districts of Boston,...

LivOnyx: Can you kill a pathogen in three seconds?

The COVID-19 pandemic has placed a hyper-focus on hygiene and infection prevention. For LivOnyx, and its President and Co-Founder Carmela Mascio, that focus is at the heart of its mission....

LEAH Knox Scholars: MLSC funding making experiences for young scientists possible

In the summer of 2019, the MLSC supported the Health Resources in Action’s LEAH (Leaders through Education, Action, & Hope) Knox Scholars Program, an MIT-based biomedical research training program that...

Interns Playing a Vital Role in a Pandemic

Massachusetts is home to countless life sciences companies working to accelerate the commercialization of promising treatments, therapies, and cures that will improve patient care. Kephera Diagnostics is one of these...

Reveal Pharmaceuticals Moves Forward

Most individuals know someone who has had, or themselves had, a contrast enhanced magnetic resonance imaging (CE-MRI) scan. CE-MRI scans offer crucial medical insight for many medical conditions, ranging from...

Reveal Pharmaceutical CEO, Vera Hoffman, and co-founders, Drs. Peter Caravan and Eric Gale

Multiple chains of opportunity: Internship Challenge key to New England Peptide’s growth strategy

New England Peptide aims to provide custom peptide and antibody products and services, enabling their clients to bring their own products to market. The company’s client base extends from coast...

Stay ahead of what’s next.